<unk>  is the process by which a person gets informed about his or her genome often in the setting of elective genetic and<unk>  testing. In contrast to genetic counseling, which focuses on Mendelian diseases and typically involves person-to-person communication with a genetic counselor or other medical genetics expert,<unk>  is not limited to currently clinically relevant information. It is often based on<unk>  information that is of interest for the informed person, such as increased risk for common complex disease that has actionable components (for example diabetes or obesity), genetically determined non-disease related traits (for example baldness), or recreational forms of information and genetic genealogy data. An individuals response to certain medications/drugs based on their pharmacogenomic profile may be provided. The need for<unk>  is currently driven by personal<unk> s companies, including 23andMe, Helix, and Pathway<unk> s. Given the wealth and complexity of information obtained by personal<unk> s tests,<unk>  can require expertise from a wide range of experts, including physicians, geneticists, molecular biologists, evolutionary biologists, population geneticists, statisticians, or bioinformaticians. Access of consumers to complete personal genomes through cheap full genome sequencing is likely to exacerbate this problem in the near future. There are currently not enough genetic counselors and clinical geneticists to help patients interpret whole-genome sequencing results regarding health-relevant information, and research shows that primary-care physicians lack the knowledge and expertise to help patients understand even single-gene test results.
Genomic counseling
Genetic counseling
Molecular risk assessment
Magnetogenetics
Preimplantation genetic haplotyping
Preimplantation genetic diagnosis
Pre-conception counseling
Molecular pathology